间充质干细胞用于COVID-19 相关脑卒中的治疗
M Rawat, C Ng, E Khan, RA Shah, S Ashfaq… - 中国神经再生研究 …, 2023 - sjzsyj.com.cn
… COVID-19 causes a predisposition to thrombotic embolism, as per the data collected
from … associated with COVID-19 had higher mortality and severe outcomes than nonCOVID-19 …
from … associated with COVID-19 had higher mortality and severe outcomes than nonCOVID-19 …
COVID-19 与慢性心衰及新冠疫苗安全有效性研究进展
韩拓， 李盈， 李成， 李沛， 张春艳， 张岩， 王聪霞 - 心脏杂志, 2023 - heartj.cn
… and pulmonary embolism, thereby exacerbating the worsening of chronic heart failure
and … ) and effectively reduce the hospitalization rate and mortality. Although vaccine-related …
and … ) and effectively reduce the hospitalization rate and mortality. Although vaccine-related …
[HTML][HTML] 新型冠状病毒感染对脑卒中患者病死率影响的Meta 分析
皇甫晓娟， 李小娟， 陈敏， 刘吉红， 翟蕊， 蔡志鹏… - 中国全科医学, 2023 - chinagp.net
… COVID-19 has been reportedly associated with a high risk of thrombotic events, which are
closely associated with … COVID-19 could increase the risk of stroke mortality, which may be …
closely associated with … COVID-19 could increase the risk of stroke mortality, which may be …
[HTML][HTML] 静脉血栓栓塞相关危险因素的研究进展
罗臻， 郭伟， 王敏 - Advances in Clinical Medicine, 2023 - hanspub.org
… common cause of death worldwide. The incidence of … of different risk factors for pulse
thromboembolism, potential … 与其他住院患者一样,COVID-19住院患者有许多常见的静脉血栓栓塞…
thromboembolism, potential … 与其他住院患者一样,COVID-19住院患者有许多常见的静脉血栓栓塞…
[HTML][HTML] COVID-19 患者深静脉血栓发生的临床特征和危险因素: 1 771 例住院患者回顾性分析
张晓华， 李传伟， 刘雨辉， 蒋小娟， 陈兰， 李力， 曹国强… - 2020 - aammt.tmmu.edu.cn
… and risk factors of deep vein thrombosis in COVID-19 patients:… critically ill patients, and the
mortality is quite elevated. Age, … treatment of venous thromboembolism associated with novel …
mortality is quite elevated. Age, … treatment of venous thromboembolism associated with novel …
血管紧张素受体阻滞剂使用对COVID-19 高血压患者病毒载量, 抗体水平和转录特征的影响
B Feng, D Zhang, Q Wang, F Yu, Q Zou, G Xie… - Journal of Zhejiang …, 2021 - Springer
… usage is not associated with aggravation of COVID-19. These … in hypertensive patients
diagnosed with COVID-19. … receptor blocker use with COVID-19 diagnosis and mortality. JAMA, …
diagnosed with COVID-19. … receptor blocker use with COVID-19 diagnosis and mortality. JAMA, …
[HTML][HTML] 慢性肝病患者接种新型冠状病毒疫苗相关研究进展
张必琼， 任红 - Advances in Clinical Medicine, 2023 - hanspub.org
… a high risk for severe COVID-19 and death. SARS-Cov-2 vaccination can reduce the disease
severity and mortality … This review focuses on the role of COVID-19 in chronic liver diseases …
severity and mortality … This review focuses on the role of COVID-19 in chronic liver diseases …
COVID-19 感染后手术时机与乳腺癌术后血栓并发症风险分析
程纬浩， 王微丽， 毕钊， 张朝蓬， 孙晓， 赵家贤… - 中国癌症 …, 2023 - china-oncology.com
… Thrombosis in hospitalized patients with COVID-19 in a New … , risk factors, and trends for
venous thromboembolism among … and risk factors in critically ill patients with COVID-19[J]. J …
venous thromboembolism among … and risk factors in critically ill patients with COVID-19[J]. J …
[HTML][HTML] 恶性肿瘤相关性静脉血栓的形成及评估现状
陈婷， 李燕 - Advances in Clinical Medicine, 2023 - hanspub.org
… 肿瘤相关静脉血栓栓塞(cancer-associated venous thromboembolism, CAVTE)是指恶性肿瘤
… 凝剂量的研究相比,VTE的患病率较低.COVID-19联合VTE患者与无VTE患者的死亡比值比为2.1 (…
… 凝剂量的研究相比,VTE的患病率较低.COVID-19联合VTE患者与无VTE患者的死亡比值比为2.1 (…
[HTML][HTML] COVID-19 与心血管代谢性疾病的临床研究进展
韩拓， 苑昊， 叶琳樱， 江旭， 白亮… - Journal of Southern …, 2021 - ncbi.nlm.nih.gov
… The high comorbidity between cardiovascular and metabolic diseases (CVMD) and
coronavirus disease 2019 (COVID-19) and the consequent high mortality and the potential risk of …
coronavirus disease 2019 (COVID-19) and the consequent high mortality and the potential risk of …